About
RNA delivery technology, Immune Activators (Adjuvants)
Areas of Focus
Categories
Drug Delivery & FormulationSeattle/Pacific Northwest
Team (56)
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
2
As Collaborator
0
Total Enrollment
96
By Phase
PHASE1: 2
By Status
RECRUITING: 1COMPLETED: 1
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2021
2022
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT06799013Lead Sponsor
Safety and Immunogenicity of a Self-Amplifying RNA Vaccine Against Crimean-Congo Hemorrhagic Fever
PHASE1Recruiting
48 participants
Started: Jul 10, 2025 · Completed: Jul 31, 2027
NCT05132907Lead Sponsor
Safety and Immunogenicity of HDT-301 Targeting a SARS-CoV-2 Variant Spike Protein
PHASE1Completed
48 participants
Started: Jan 24, 2022 · Completed: May 30, 2024
Locations (1)
Headquarters
Seattle, WA, United States
Map
Loading map...